VAN HOUTE HANS (Chief Financial Officer) sold 6.0% of their position (2.85K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $66.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.75K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.86K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+3.57K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−2.85K
Price / share
$23.38
Trade value
$66.52K
% of position
Net shares
+7.33K
Net value
-$66.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +3.75K | — | — | 10.0% | 37.59K | 41.34K |
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +2.86K | — | — | 6.9% | 41.34K | 44.20K |
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +3.57K | — | — | 8.1% | 44.20K | 47.77K |
| Common Stock Direct | 7/30/2026 | S · Sale | −2.85K | $23.38 | $66.52K | 6.0% | 47.77K | 44.93K |
| Total | +7.33K | -$66.52K | ||||||
Restricted Stock Units
Common Stock
3.75K shares
Shares
−3.75K
Strike price
0
Held after
11.25K
Exercisable
—
Restricted Stock Units
Common Stock
2.86K shares
Shares
−2.86K
Strike price
0
Held after
20.01K
Exercisable
—
Restricted Stock Units
Common Stock
3.57K shares
Shares
−3.57K
Strike price
0
Held after
39.30K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 7/30/2026 | M · Option Exercise | −3.75K | 0 | — | 11.25K |
| Restricted Stock Units Direct | Common Stock2.86K shares | 7/30/2026 | M · Option Exercise | −2.86K | 0 | — | 20.01K |
| Restricted Stock Units Direct | Common Stock3.57K shares | 7/30/2026 | M · Option Exercise | −3.57K | 0 | — | 39.30K |